SecBot SecBot
8-K ·Filed May 5, 2026

LMAT

LEMAITRE VASCULAR INC
BULLISH
Impact 7/10
Horizondays Processed6mo ago SEC0001193125-26-206578
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The beat on EPS and raised full-year guidance indicate sustained operational leverage. With gross margins expanding and international momentum strong (EMEA +20%, APAC +18%), watch for further upside to estimates. The stock should react positively in the near term.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$110.22
T+0 close · May 5, 2026 · via day close
Latest settled
−8.07%
T+60 · $101.32
Vs SPY
−10.14%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 6 $110.22entry
  2. T+1 · 6mo ago −2.10%α −1.76% · $107.91
  3. T+5 · 6mo ago −11.79%α −12.93% · $97.22
  4. T+20 · 6mo ago −16.86%α −19.64% · $91.64
  5. T+60 · 4mo ago −8.07%α −10.14% · $101.32

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

LeMaitre Vascular reported Q1 2026 EPS of $0.68 (+42% YoY), a 3% beat on consensus of $0.66, on revenue of $66.6M (+11% YoY, in line with $66.7M consensus). The company raised full-year 2026 guidance: operating income midpoint increased to $79.8M (from $77.8M) and EPS to $3.00 (from $2.91), implying 24% adjusted EPS growth. Gross margin expanded 350 bps to 72.7%, and all product lines and geographies posted record sales.

Key Financial Metrics

EPS
$0.68
est $0.66 · +3.0%
Revenue
$66.6M
est $66.7M · -0.2% · +11.2% YoY
Rating
beat
Guidance
$277M-$283M
raised
Gross Margin
72.7%

Key Facts

  • Q1 2026 EPS $0.68 beat consensus ($0.66) by 3.0%
  • Q1 sales $66.6M (+11% YoY, +10% organic), in line with guidance midpoint
  • Gross margin 72.7% (+350 bps YoY); operating margin 27% (+570 bps)
  • Full-year 2026 guidance raised: revenue $277M–$283M (midpoint $280M, +12%), EPS $2.93–$3.08 (midpoint $3.00, +19%/+26% adjusted)
  • Artegraft grew 36% worldwide; all three geographies posted record sales

Financial Impact

EPS beat of $0.02 vs consensus; guidance raised by $0.09 at midpoint

revenueepsgross marginoperating income

Risk Factors

  • Revenue slightly below consensus by ~$0.15M (0.2% miss) may be noted by some
  • Currency headwinds impacted reported sales by ~$2M in Q1
  • Guidance assumes no further macroeconomic deterioration

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
69% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-206578
Document: d94324d8k.htm0001193125-26-206578
Document: 0001193125-26-206578-index-headers.html0001193125-26-206578
Document: 0001193125-26-206578-index.html0001193125-26-206578
Document: 0001193125-26-206578.txt0001193125-26-206578
8-K Data (Synthetic)0001193125-26-206578

Track record

14 reports on LMAT

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +15.08% at T+20 after the May 7, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 4, 202612d ago 8-K Bearish 6/10 Entry $83.49 to $77.65 Now $77.01 +7.76% ▲ +6.99% +10.29% vs SPY
  2. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $80.60 to $79.02 Now $77.01 −4.45% ▼ −1.96% −1.37% vs SPY
  3. Oct 15, 20264w ago 8-K Neutral 2/10 Entry $80.82 to $84.45 Now $77.01 −4.71% ▲ +4.49% +4.40% vs SPY
  4. Aug 27, 202611w ago Press Release Neutral 2/10 Entry $80.45 to $80.67 Now $77.01 −4.28% ▲ +0.27% +0.16% vs SPY
  5. Jul 14, 202617w ago Press Release Neutral 1/10 Entry $99.79 Now $77.01 −22.83% No price data
  6. May 7, 202627w ago Insider Cluster Bearish 4/10 Entry $107.91 to $98.17 Now $77.01 +28.63% ▲ +9.03% +10.53% vs SPY
  7. May 7, 202627w ago Insider Cluster Neutral 2/10 Entry $107.91 to $98.17 Now $77.01 −28.63% ▼ −9.03% −10.53% vs SPY
  8. May 7, 202627w ago Insider Cluster Neutral 3/10 Entry $107.91 to $98.17 Now $77.01 −28.63% ▼ −9.03% −10.53% vs SPY
  9. May 5, 202627w ago 8-K Bullish 7/10 Viewing Entry $110.22 to $97.22 Now $77.01 −30.13% ▼ −11.79% −12.93% vs SPY
  10. Apr 14, 202630w ago DEFA14A Neutral 3/10 Entry $117.39 to $111.90 Now $77.01 −34.40% ▼ −4.68% −6.07% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026